Результаты квартальной отчетности Covalon Technologies превзошли ожидания аналитиков

Covalon Technologies (OTCMKTS:CVALF – Get Free Report) announced its quarterly earnings results on Thursday. The company reported $0.07 earnings per share for the quarter, topping analysts’ consensus estimates of $0.02 by $0.05, Zacks reports. Covalon Technologies had a net margin of 5.05% and a return on equity of 5.77%. Covalon Technologies Stock Down 0.8% CVALF opened at $1.66 on Thursday. The stock has a market cap of $45.71 million, a P/E ratio of 41.39 and a beta of 0.59. Covalon Technologies has a 12 month low of $1.16 and a 12 month high of $1.74. The company has a fifty day simple moving average of $1.57 and a 200 day simple moving average of $1.45. Covalon Technologies Company Profile Covalon Technologies Ltd. (OTCMKTS:CVALF) is a Canadian medical device and life sciences company specializing in advanced wound care and infection prevention solutions. Based in Toronto, Ontario, Covalon leverages proprietary photochemical bonding technology to create antimicrobial and anti-adhesion polymer coatings for a range of medical devices and wound dressings. The company’s core focus is on reducing surgical site infections and improving healing outcomes through innovative biomaterials. The company’s product portfolio comprises hydrogel-based wound dressings and polymer-coated medical device components. Featured Articles Receive News & Ratings for Covalon Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covalon Technologies and related companies with MarketBeat.com's FREE daily email newsletter.